D-0873-2016 Class I Terminated

Recalled by Sanofi-Aventis U.S. LLC — Bridgewater, NJ

FDA drug recall D-0873-2016 was initiated by Sanofi-Aventis U.S. LLC on Oct 28, 2015 and is designated Class I. Reason for recall: Defective Delivery System; potential to have inaccurate dosage delivery The recall status is terminated (terminated Jul 15, 2025). Affected quantity: 159,000 prefilled injectors.

Recall details

Product Type
Drugs
Report Date
Jun 1, 2016
Initiation Date
Oct 28, 2015
Termination Date
Jul 15, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
159,000 prefilled injectors

Product description

Auvi-Q (epinephrine injection, USP) Auto-Injector, 0.15 mg (a) 2 prefilled auto injectors + 1 trainer (NDC 0024-5831-02) and (b) 1 prefilled auto injector + 1 trainer (NDC 0024-5831-00), Rx Only, Manufactured for Sanofi-Aventis US, LLC Bridgewater, NJ 08807 A Sanofi Company

Reason for recall

Defective Delivery System; potential to have inaccurate dosage delivery

Distribution pattern

Nationwide

Code information

a) 2144144, exp 10/2015; 2469674, exp 04/2016; 2506492, 2546978, 2546979, exp 05/2016; 2654817, 2654818, exp 06/2016; 2692143, 2692144, exp 07/2016; 2719838, exp 08/2016; 2824845, 2891021, 2857530, exp 09/2016; 2883631, 2883632, exp 10/2016; 2883633, 2945429, 3028243, exp 11/2016; 3037230, 2966680, 2974276, 2974280, exp 12/2016; and b) 2525474, exp 05/2016

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0873-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0873-2016. Report a data issue: hello@regdatalab.com.